These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19399357)

  • 1. Metabolic syndrome: a follow-up study of acute depressive inpatients.
    Richter N; Juckel G; Assion HJ
    Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):41-9. PubMed ID: 19399357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metabolic syndrome and clinical features on functioning in patients with bipolar disorder: a cross-sectional study.
    Kocakaya H; Songur E; Batmaz S; Çelikbaş Z; Küçük Ö
    Braz J Psychiatry; 2020 Aug; 42(4):373-381. PubMed ID: 32187318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study.
    Akbaraly TN; Kivimäki M; Brunner EJ; Chandola T; Marmot MG; Singh-Manoux A; Ferrie JE
    Diabetes Care; 2009 Mar; 32(3):499-504. PubMed ID: 19106378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between depressive symptoms and cognitive impairment in patients with metabolic syndrome.
    Kopchak O; Pulyk O
    Wiad Lek; 2017; 70(4):737-741. PubMed ID: 29064796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and depression: a cross-sectional analysis.
    Heiskanen TH; Niskanen LK; Hintikka JJ; Koivumaa-Honkanen HT; Honkalampi KM; Haatainen KM; Viinamäki HT
    J Clin Psychiatry; 2006 Sep; 67(9):1422-7. PubMed ID: 17017829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.
    Tafalla M; Sanchez-Moreno J; Diez T; Vieta E
    J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic risks and omega-3 index in recent-onset bipolar I disorder.
    Wulsin LR; Blom TJ; Durling M; Welge JA; DelBello MP; Adler CM; McNamara RK; Strakowski SM
    Bipolar Disord; 2018 Nov; 20(7):658-665. PubMed ID: 29479787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome, depression and anhedonia among young adults.
    Moreira FP; Jansen K; Cardoso TA; Mondin TC; Vieira IS; Magalhães PVDS; Kapczinski F; Souza LDM; da Silva RA; Oses JP; Wiener CD
    Psychiatry Res; 2019 Jan; 271():306-310. PubMed ID: 30522000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic dysregulation and late-life depression: a prospective study.
    Marijnissen RM; Vogelzangs N; Mulder ME; van den Brink RH; Comijs HC; Oude Voshaar RC
    Psychol Med; 2017 Apr; 47(6):1041-1052. PubMed ID: 27938429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome.
    Chirinos DA; Goldberg R; Gellman M; Mendez AJ; Gutt M; McCalla JR; Llabre MM; Schneiderman N
    Ann Behav Med; 2013 Aug; 46(1):31-9. PubMed ID: 23436275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
    Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B
    Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Schennach R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Psychopathology; 2012; 45(5):276-85. PubMed ID: 22796716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Hamilton depression rating scale (5 items) for manic and mixed bipolar disorders.
    González-Pinto A; Mosquera F; Reed C; Novick D; Barbeito S; Vega P; Bertsch J; Alberich S; Haro JM
    J Nerv Ment Dis; 2009 Sep; 197(9):682-6. PubMed ID: 19752648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder.
    McIntyre RS; Fayyad R; Mackell JA; Boucher M
    Curr Med Res Opin; 2016; 32(3):587-99. PubMed ID: 26709542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.